United States Polymer Drug Conjugates Market Report 2017

United States Polymer Drug Conjugates Market Report 2017

1 Polymer Drug Conjugates Overview

1.1 Product Overview and Scope of Polymer Drug Conjugates

1.2 Classification of Polymer Drug Conjugates by Product Category

1.2.1 United States Polymer Drug Conjugates Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Polymer Drug Conjugates Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Polymer-Dox Conjugates

1.2.4 Polymer-Paclitaxel Conjugates

1.2.5 Polymer-Camptothecin Conjugates

1.2.6 Polymer-Platinate Conjugates

1.3 United States Polymer Drug Conjugates Market by Application/End Users

1.3.1 United States Polymer Drug Conjugates Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Cancer Treatment

1.3.3 Leukmia

1.3.4 Hepatitis

1.3.5 Others

1.4 United States Polymer Drug Conjugates Market by Region

1.4.1 United States Polymer Drug Conjugates Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Polymer Drug Conjugates Status and Prospect (2012-2022)

1.4.3 Southwest Polymer Drug Conjugates Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Polymer Drug Conjugates Status and Prospect (2012-2022)

1.4.5 New England Polymer Drug Conjugates Status and Prospect (2012-2022)

1.4.6 The South Polymer Drug Conjugates Status and Prospect (2012-2022)

1.4.7 The Midwest Polymer Drug Conjugates Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Polymer Drug Conjugates (2012-2022)

1.5.1 United States Polymer Drug Conjugates Sales and Growth Rate (2012-2022)

1.5.2 United States Polymer Drug Conjugates Revenue and Growth Rate (2012-2022)

2 United States Polymer Drug Conjugates Market Competition by Players/Suppliers

2.1 United States Polymer Drug Conjugates Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Polymer Drug Conjugates Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Polymer Drug Conjugates Average Price by Players/Suppliers (2012-2017)

2.4 United States Polymer Drug Conjugates Market Competitive Situation and Trends

2.4.1 United States Polymer Drug Conjugates Market Concentration Rate

2.4.2 United States Polymer Drug Conjugates Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Polymer Drug Conjugates Manufacturing Base Distribution, Sales Area, Product Type

3 United States Polymer Drug Conjugates Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Polymer Drug Conjugates Sales and Market Share by Region (2012-2017)

3.2 United States Polymer Drug Conjugates Revenue and Market Share by Region (2012-2017)

3.3 United States Polymer Drug Conjugates Price by Region (2012-2017)

4 United States Polymer Drug Conjugates Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Polymer Drug Conjugates Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Polymer Drug Conjugates Revenue and Market Share by Type (2012-2017)

4.3 United States Polymer Drug Conjugates Price by Type (2012-2017)

4.4 United States Polymer Drug Conjugates Sales Growth Rate by Type (2012-2017)

5 United States Polymer Drug Conjugates Sales (Volume) by Application (2012-2017)

5.1 United States Polymer Drug Conjugates Sales and Market Share by Application (2012-2017)

5.2 United States Polymer Drug Conjugates Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Polymer Drug Conjugates Players/Suppliers Profiles and Sales Data

6.1 3S Bio

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Polymer Drug Conjugates Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 3S Bio Polymer Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Abeona Therapeutics

6.2.2 Polymer Drug Conjugates Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Abeona Therapeutics Polymer Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Abramson Cancer Center

6.3.2 Polymer Drug Conjugates Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Abramson Cancer Center Polymer Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Access Pharmaceuticals

6.4.2 Polymer Drug Conjugates Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Access Pharmaceuticals Polymer Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Adama

6.5.2 Polymer Drug Conjugates Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Adama Polymer Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Eyetech

6.6.2 Polymer Drug Conjugates Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Eyetech Polymer Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Ferring

6.7.2 Polymer Drug Conjugates Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Ferring Polymer Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Flamel Technologies

6.8.2 Polymer Drug Conjugates Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Flamel Technologies Polymer Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Genentech

6.9.2 Polymer Drug Conjugates Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Genentech Polymer Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 GlaxoSmithKline

6.10.2 Polymer Drug Conjugates Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 GlaxoSmithKline Polymer Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Gowan

6.12 Gynecologic Oncology Group Foundation

6.13 JenKem Technology

6.14 Landec

6.15 Lipotek

7 Polymer Drug Conjugates Manufacturing Cost Analysis

7.1 Polymer Drug Conjugates Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Polymer Drug Conjugates

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Polymer Drug Conjugates Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Polymer Drug Conjugates Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Polymer Drug Conjugates Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Polymer Drug Conjugates Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Polymer Drug Conjugates Sales Volume Forecast by Type (2017-2022)

11.3 United States Polymer Drug Conjugates Sales Volume Forecast by Application (2017-2022)

11.4 United States Polymer Drug Conjugates Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Polymer Drug Conjugates

Figure United States Polymer Drug Conjugates Market Size (K Units) by Type (2012-2022)

Figure United States Polymer Drug Conjugates Sales Volume Market Share by Type (Product Category) in 2016

Figure Polymer-Dox Conjugates Product Picture

Figure Polymer-Paclitaxel Conjugates Product Picture

Figure Polymer-Camptothecin Conjugates Product Picture

Figure Polymer-Platinate Conjugates Product Picture

Figure United States Polymer Drug Conjugates Market Size (K Units) by Application (2012-2022)

Figure United States Sales Market Share of Polymer Drug Conjugates by Application in 2016

Figure Cancer Treatment Examples

Table Key Downstream Customer in Cancer Treatment

Figure Leukmia Examples

Table Key Downstream Customer in Leukmia

Figure Hepatitis Examples

Table Key Downstream Customer in Hepatitis

Figure Others Examples

Table Key Downstream Customer in Others

Figure United States Polymer Drug Conjugates Market Size (Million USD) by Region (2012-2022)

Figure The West Polymer Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Polymer Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Polymer Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Polymer Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Polymer Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Polymer Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Polymer Drug Conjugates Sales (K Units) and Growth Rate (2012-2022)

Figure United States Polymer Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Polymer Drug Conjugates Market Major Players Product Sales Volume (K Units) (2012-2017)

Table United States Polymer Drug Conjugates Sales (K Units) of Key Players/Suppliers (2012-2017)

Table United States Polymer Drug Conjugates Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Polymer Drug Conjugates Sales Share by Players/Suppliers

Figure 2017 United States Polymer Drug Conjugates Sales Share by Players/Suppliers

Figure United States Polymer Drug Conjugates Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Polymer Drug Conjugates Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Polymer Drug Conjugates Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Polymer Drug Conjugates Revenue Share by Players/Suppliers

Figure 2017 United States Polymer Drug Conjugates Revenue Share by Players/Suppliers

Table United States Market Polymer Drug Conjugates Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)

Figure United States Market Polymer Drug Conjugates Average Price (USD/Unit) of Key Players/Suppliers in 2016

Figure United States Polymer Drug Conjugates Market Share of Top 3 Players/Suppliers

Figure United States Polymer Drug Conjugates Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Polymer Drug Conjugates Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Polymer Drug Conjugates Product Category

Table United States Polymer Drug Conjugates Sales (K Units) by Region (2012-2017)

Table United States Polymer Drug Conjugates Sales Share by Region (2012-2017)

Figure United States Polymer Drug Conjugates Sales Share by Region (2012-2017)

Figure United States Polymer Drug Conjugates Sales Market Share by Region in 2016

Table United States Polymer Drug Conjugates Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Polymer Drug Conjugates Revenue Share by Region (2012-2017)

Figure United States Polymer Drug Conjugates Revenue Market Share by Region (2012-2017)

Figure United States Polymer Drug Conjugates Revenue Market Share by Region in 2016

Table United States Polymer Drug Conjugates Price (USD/Unit) by Region (2012-2017)

Table United States Polymer Drug Conjugates Sales (K Units) by Type (2012-2017)

Table United States Polymer Drug Conjugates Sales Share by Type (2012-2017)

Figure United States Polymer Drug Conjugates Sales Share by Type (2012-2017)

Figure United States Polymer Drug Conjugates Sales Market Share by Type in 2016

Table United States Polymer Drug Conjugates Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Polymer Drug Conjugates Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Polymer Drug Conjugates by Type (2012-2017)

Figure Revenue Market Share of Polymer Drug Conjugates by Type in 2016

Table United States Polymer Drug Conjugates Price (USD/Unit) by Types (2012-2017)

Figure United States Polymer Drug Conjugates Sales Growth Rate by Type (2012-2017)

Table United States Polymer Drug Conjugates Sales (K Units) by Application (2012-2017)

Table United States Polymer Drug Conjugates Sales Market Share by Application (2012-2017)

Figure United States Polymer Drug Conjugates Sales Market Share by Application (2012-2017)

Figure United States Polymer Drug Conjugates Sales Market Share by Application in 2016

Table United States Polymer Drug Conjugates Sales Growth Rate by Application (2012-2017)

Figure United States Polymer Drug Conjugates Sales Growth Rate by Application (2012-2017)

Table 3S Bio Basic Information List

Table 3S Bio Polymer Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure 3S Bio Polymer Drug Conjugates Sales Growth Rate (2012-2017)

Figure 3S Bio Polymer Drug Conjugates Sales Market Share in United States (2012-2017)

Figure 3S Bio Polymer Drug Conjugates Revenue Market Share in United States (2012-2017)

Table Abeona Therapeutics Basic Information List

Table Abeona Therapeutics Polymer Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Abeona Therapeutics Polymer Drug Conjugates Sales Growth Rate (2012-2017)

Figure Abeona Therapeutics Polymer Drug Conjugates Sales Market Share in United States (2012-2017)

Figure Abeona Therapeutics Polymer Drug Conjugates Revenue Market Share in United States (2012-2017)

Table Abramson Cancer Center Basic Information List

Table Abramson Cancer Center Polymer Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Abramson Cancer Center Polymer Drug Conjugates Sales Growth Rate (2012-2017)

Figure Abramson Cancer Center Polymer Drug Conjugates Sales Market Share in United States (2012-2017)

Figure Abramson Cancer Center Polymer Drug Conjugates Revenue Market Share in United States (2012-2017)

Table Access Pharmaceuticals Basic Information List

Table Access Pharmaceuticals Polymer Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Access Pharmaceuticals Polymer Drug Conjugates Sales Growth Rate (2012-2017)

Figure Access Pharmaceuticals Polymer Drug Conjugates Sales Market Share in United States (2012-2017)

Figure Access Pharmaceuticals Polymer Drug Conjugates Revenue Market Share in United States (2012-2017)

Table Adama Basic Information List

Table Adama Polymer Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Adama Polymer Drug Conjugates Sales Growth Rate (2012-2017)

Figure Adama Polymer Drug Conjugates Sales Market Share in United States (2012-2017)

Figure Adama Polymer Drug Conjugates Revenue Market Share in United States (2012-2017)

Table Eyetech Basic Information List

Table Eyetech Polymer Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Eyetech Polymer Drug Conjugates Sales Growth Rate (2012-2017)

Figure Eyetech Polymer Drug Conjugates Sales Market Share in United States (2012-2017)

Figure Eyetech Polymer Drug Conjugates Revenue Market Share in United States (2012-2017)

Table Ferring Basic Information List

Table Ferring Polymer Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Ferring Polymer Drug Conjugates Sales Growth Rate (2012-2017)

Figure Ferring Polymer Drug Conjugates Sales Market Share in United States (2012-2017)

Figure Ferring Polymer Drug Conjugates Revenue Market Share in United States (2012-2017)

Table Flamel Technologies Basic Information List

Table Flamel Technologies Polymer Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Flamel Technologies Polymer Drug Conjugates Sales Growth Rate (2012-2017)

Figure Flamel Technologies Polymer Drug Conjugates Sales Market Share in United States (2012-2017)

Figure Flamel Technologies Polymer Drug Conjugates Revenue Market Share in United States (2012-2017)

Table Genentech Basic Information List

Table Genentech Polymer Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Genentech Polymer Drug Conjugates Sales Growth Rate (2012-2017)

Figure Genentech Polymer Drug Conjugates Sales Market Share in United States (2012-2017)

Figure Genentech Polymer Drug Conjugates Revenue Market Share in United States (2012-2017)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Polymer Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure GlaxoSmithKline Polymer Drug Conjugates Sales Growth Rate (2012-2017)

Figure GlaxoSmithKline Polymer Drug Conjugates Sales Market Share in United States (2012-2017)

Figure GlaxoSmithKline Polymer Drug Conjugates Revenue Market Share in United States (2012-2017)

Table Gowan Basic Information List

Table Gynecologic Oncology Group Foundation Basic Information List

Table JenKem Technology Basic Information List

Table Landec Basic Information List

Table Lipotek Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Polymer Drug Conjugates

Figure Manufacturing Process Analysis of Polymer Drug Conjugates

Figure Polymer Drug Conjugates Industrial Chain Analysis

Table Raw Materials Sources of Polymer Drug Conjugates Major Players/Suppliers in 2016

Table Major Buyers of Polymer Drug Conjugates

Table Distributors/Traders List

Figure United States Polymer Drug Conjugates Sales Volume (K Units) and Growth Rate Forecast (2017-2022)

Figure United States Polymer Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Polymer Drug Conjugates Price (USD/Unit) Trend Forecast (2017-2022)

Table United States Polymer Drug Conjugates Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Polymer Drug Conjugates Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Polymer Drug Conjugates Sales Volume (K Units) Forecast by Type in 2022

Table United States Polymer Drug Conjugates Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Polymer Drug Conjugates Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Polymer Drug Conjugates Sales Volume (K Units) Forecast by Application in 2022

Table United States Polymer Drug Conjugates Sales Volume (K Units) Forecast by Region (2017-2022)

Table United States Polymer Drug Conjugates Sales Volume Share Forecast by Region (2017-2022)

Figure United States Polymer Drug Conjugates Sales Volume Share Forecast by Region (2017-2022)

Figure United States Polymer Drug Conjugates Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources